Belgium's Cartagenia Sets Up East Coast Shop to Expand North American Footprint | GenomeWeb

By Uduak Grace Thomas

Belgian clinical bioinformatics firm Cartagenia is moving aggressively into the North American market with a new US office, a growing sales staff, and several new US customers.

The company said this week that it has opened a new office in Boston, Mass., that will be led by Drew Arnold, who will serve as vice president of sales and business development for North America. Prior to joining the company, Arnold led the global sales team for competitor GenomeQuest.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nature this week: weighting scheme increases GWAS power, and more.

Marc Tessier-Lavigne is to be the next president of Stanford University.

Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.

Journals and research funding agencies pledge to enable the sharing of Zika virus research.

Feb
25
Sponsored by
Omicia

This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.